Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi, N Mhlongo, ME Soliman - Drug design, development and …, 2017 - Taylor & Francis
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
Metal complexes in cancer therapy--an update from drug design perspective
U Ndagi, N Mhlongo, ME Soliman - Drug Design, Development and …, 2017 - go.gale.com
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
[HTML][HTML] Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi, N Mhlongo, ME Soliman - Drug Design, Development …, 2017 - ncbi.nlm.nih.gov
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
[PDF][PDF] Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi - Drug Design, Development and Therapy, 2017 - scienceopen.com
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
Metal complexes in cancer therapy-an update from drug design perspective.
U Ndagi, N Mhlongo, ME Soliman - Drug Design, Development and …, 2017 - europepmc.org
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
[引用][C] Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi, N Mhlongo, M Soliman - Drug Design, Development and …, 2017 - cir.nii.ac.jp
Metal complexes in cancer therapy – an update from drug design perspective | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi, N Mhlongo… - Drug Design, Development …, 2017 - search.proquest.com
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
[PDF][PDF] Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi - Drug Design, Development and Therapy, 2017 - core.ac.uk
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
Metal complexes in cancer therapy-an update from drug design perspective
U Ndagi, N Mhlongo… - Drug design …, 2017 - pubmed.ncbi.nlm.nih.gov
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi, N Mhlongo, ME Soliman - Drug Design, Development and …, 2017 - dovepress.com
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …